Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Zippelius

Showing results (41-50 of 163) with videos related to

Pageof 17
Sort By:
Swiss Medical Weekly|November 11, 2019
Toxicity associated with PD-1 blockade after allogeneic haematopoietic cell transplantationGuacimara Ortega Sanchez, Frank Stenner, Stephan Dirnhofer, et al.
STAR Protocols|May 7, 2023
Protocol for ex vivo culture of patient-derived tumor fragmentsLisanne M Roelofsen, Paula Voabil, Marjolein de Bruijn, et al.
Swiss Medical Weekly|May 15, 2018
Immunotherapy in head and neck cancer - scientific rationale, current treatment options and future directionsUta Rothschild, Laurent Muller, Axel Lechner, et al.
Targeted Oncology|September 22, 2019
Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX)Heike Liewen, Norbert Markuly, Heinz Läubli, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Tumor-specific crosslinking of GITR as costimulation for immunotherapyTanja Burckhart, Markus Thiel, Hiroyoshi Nishikawa, et al.
Scientific Reports|January 14, 2018
Targeting Insulin-Like Growth Factor-I and Extracellular Matrix Interactions in Melanoma ProgressionBerline Murekatete, Ali Shokoohmand, Jacqui McGovern, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2014
The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunityKea Martin, Philipp Müller, Jens Schreiner, et al.
Dermatology (Basel, Switzerland)|December 5, 2014
Vemurafenib-induced radiation recall dermatitis: case report and review of the literatureKatrin Conen, Katarzyna Mosna-Firlejczyk, Christoph Rochlitz, et al.
Swiss Medical Weekly|October 14, 2025
Exacerbation of demyelinating polyneuropathy after adoptive cell therapy with tumour-infiltrating lymphocytes by metastatic melanomaElisa Canini, Lorenza Pacchin, Ann Kristine Blackham, et al.
Frontiers in Oncology|October 5, 2023
Clinical and pathological factors and outcome of central nervous system metastasis in breast cancerDimitri Dettwiler, Elena-Diana Chiru, Eveline Daetwyler, et al.
Pageof 17

Showing results (41-50 of 163) with videos related to

Sort By:
Pageof 17
Swiss Medical Weekly|November 11, 2019
Toxicity associated with PD-1 blockade after allogeneic haematopoietic cell transplantationGuacimara Ortega Sanchez, Frank Stenner, Stephan Dirnhofer, et al.
STAR Protocols|May 7, 2023
Protocol for ex vivo culture of patient-derived tumor fragmentsLisanne M Roelofsen, Paula Voabil, Marjolein de Bruijn, et al.
Swiss Medical Weekly|May 15, 2018
Immunotherapy in head and neck cancer - scientific rationale, current treatment options and future directionsUta Rothschild, Laurent Muller, Axel Lechner, et al.
Targeted Oncology|September 22, 2019
Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX)Heike Liewen, Norbert Markuly, Heinz Läubli, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Tumor-specific crosslinking of GITR as costimulation for immunotherapyTanja Burckhart, Markus Thiel, Hiroyoshi Nishikawa, et al.
Scientific Reports|January 14, 2018
Targeting Insulin-Like Growth Factor-I and Extracellular Matrix Interactions in Melanoma ProgressionBerline Murekatete, Ali Shokoohmand, Jacqui McGovern, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2014
The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunityKea Martin, Philipp Müller, Jens Schreiner, et al.
Dermatology (Basel, Switzerland)|December 5, 2014
Vemurafenib-induced radiation recall dermatitis: case report and review of the literatureKatrin Conen, Katarzyna Mosna-Firlejczyk, Christoph Rochlitz, et al.
Swiss Medical Weekly|October 14, 2025
Exacerbation of demyelinating polyneuropathy after adoptive cell therapy with tumour-infiltrating lymphocytes by metastatic melanomaElisa Canini, Lorenza Pacchin, Ann Kristine Blackham, et al.
Frontiers in Oncology|October 5, 2023
Clinical and pathological factors and outcome of central nervous system metastasis in breast cancerDimitri Dettwiler, Elena-Diana Chiru, Eveline Daetwyler, et al.
Pageof 17